Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic Acid copolymer: preliminary results.

@article{Puri2003TreatmentOV,
  title={Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic Acid copolymer: preliminary results.},
  author={Prem Puri and Boris Chertin and Murugesh Velayudham and Laxaman Dass and Eric A. Colhoun},
  journal={The Journal of urology},
  year={2003},
  volume={170 4 Pt 2},
  pages={1541-4; discussion 1544}
}
PURPOSE Endoscopic subureteral injection of tissue augmenting substances has become an established alternative to long-term antibiotic prophylaxis and open surgery for the management of vesicoureteral reflux (VUR) in children. Recently, dextranomer/hyaluronic acid copolymer (Deflux, Q-Med AB, Uppsala, Sweden) a biodegradable injectable material has been reported to be a promising alternative to other tissue augmenting substances. However, the experience with dextranomer/hyaluronic acid… CONTINUE READING